A Study to Evaluate Safety, Pharmacokinetic, and Biological Activity of INCB059872 in Subjects With Sickle Cell Disease

NCT03132324 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
12
Enrollment
INDUSTRY
Sponsor class

Stopped This study is terminated due to a business decision not to pursue INCB059782 in Sickle Cell Disease indication.

Conditions

Interventions

Sponsor

Incyte Corporation